Official EU label nameGlossary entry 25621

SERRALYSIN

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:37312-62-2

EC:253-457-5

Ingredient index records:

SERRALYSIN

Cosmetic functions: SKIN CONDITIONING, SKIN CONDITIONING - EMOLLIENT

Serralysin is the enzyme produced by the fermentation of Serratia marcescens

Open full local profile

1 matched or reported name

SERRALYSIN

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name SERRALYSIN.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 37312-62-2

CAS 37312-62-2PubChem CID 171666295

Serrapeptase

Serrapeptase is a proteolytic enzyme preparation used concomitantly with an antibiotic in osteoarticular infections. Serratiopeptidase is under investigation in clinical trial NCT02493179 (Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery). — DrugBank

IUPAC name: (11Z)-17-hydroxy-2-phenyl-9-oxa-1,5,14,21-tetrazatetracyclo[12.7.1.03,8.016,21]docosa-3(8),4,6,11,16,19-hexaene-15,18-dione

Molecular formula: C46H40N8O8
Molecular weight: 832.9 g/mol
Exact mass: 832.29691026 Da
Topological polar surface area: 172.0 Å²
Hydrogen-bond donors: 2
Hydrogen-bond acceptors: 14
Covalent units: 2
Defined stereocentres: 0

Also known as

SerratiopeptidaseSerrapeptase (JAN)SERRAPEPTASE [JAN]Serrapeptasum (INN-Latin)Serrapeptasum [INN-Latin]Serrapeptasa (INN-Spanish)Serrapeptasa [INN-Spanish]Dasen

16 more reported names

serrapeptasiAniflazimeSerralysinSerrapeptasaSerrapeptasumAniflazymIrzaimPeptizyme SPSerratio peptidaseIrzaim (TN)Serrapeptase [INN]RefChem:884940SERRALYSIN [INCI]SERRAPEPTASE [JP]NL053ABE4JSERRAPEPTASE [WHO-DD]

Open full PubChem record PubChem annotations 3D structure image

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision